Osborn Williams & Donohoe’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$3.08M Buy
41,976
+1,612
+4% +$127K 0.4% 72
2019
Q4
$3.5M Sell
40,364
-655
-2% -$53.8K 0.35% 82
2019
Q3
$3.29M Sell
41,019
-1,166
-3% -$93.4K 0.33% 83
2019
Q2
$3.38M Buy
42,185
+723
+2% +$55.4K 0.35% 84
2019
Q1
$3.16M Buy
41,462
+7,008
+20% +$524K 0.32% 86
2018
Q4
$2.51M Sell
34,454
-1,268
-4% -$89.5K 0.44% 63
2018
Q3
$2.42M Buy
35,722
+1,100
+3% +$70.1K 0.38% 73
2018
Q2
$2M Sell
34,622
-340
-1% -$19.2K 0.34% 80
2018
Q1
$1.82M Sell
34,962
-1,415
-4% -$76.4K 0.31% 83
2017
Q4
$1.95M Sell
36,377
-353
-1% -$19.6K 0.33% 81
2017
Q3
$2.24M Sell
36,730
-210
-0.6% -$12.7K 0.4% 69
2017
Q2
$2.26M Buy
36,940
+125
+0.3% +$7.61K 0.41% 67
2017
Q1
$2.23M Buy
36,815
+236
+0.6% +$14.3K 0.4% 71
2016
Q4
$2.06M Sell
36,579
-453
-1% -$26.5K 0.39% 69
2016
Q3
$2.21M Buy
37,032
+1,591
+4% +$93K 0.42% 70
2016
Q2
$1.95M Buy
35,441
+1,129
+3% +$60.1K 0.38% 70
2016
Q1
$1.73M Buy
34,312
+1,668
+5% +$81.7K 0.35% 75
2015
Q4
$1.65M Sell
32,644
-157
-0.5% -$7.92K 0.34% 73
2015
Q3
$1.55M Buy
32,801
+471
+1% +$25K 0.34% 75
2015
Q2
$1.77M Sell
32,330
-760
-2% -$42.6K 0.36% 73
2015
Q1
$1.81M Buy
33,090
+1,517
+5% +$85.9K 0.35% 77
2014
Q4
$1.71M Sell
31,573
-760
-2% -$42.3K 0.34% 80
2014
Q3
$1.83M Sell
32,333
-838
-3% -$47.1K 0.38% 74
2014
Q2
$1.85M Hold
33,171
0.38% 74
2014
Q1
$1.8M Buy
33,171
+2,017
+6% +$104K 0.4% 75
2013
Q4
$1.49M Hold
31,154
0.33% 79
2013
Q3
$1.42M Buy
31,154
+232
+0.8% +$10.6K 0.35% 81
2013
Q2
$1.37M Buy
+30,922
New +$1.38M 0.36% 78

Other funds holding MRK

Osborn Williams & Donohoe's MRK Position: Q1 2020 in Review

Osborn Williams & Donohoe increased its Merck (MRK) stake by 4% in Q1 2020, buying an estimated $127K and bringing the position to 41,976 shares worth $3.08M. The position accounts for 0.4% of the portfolio, ranked #72.

Osborn Williams & Donohoe first reported a position in MRK in Q2 2013 and has held it in 28 quarters since. The position peaked at $3.5M in Q4 2019. 2,477 funds tracked by Wall St. Rank hold MRK as of Q1 2020.

  • Osborn Williams & Donohoe held 41,976 shares of Merck worth $3.08M as of Q1 2020.
  • Osborn Williams & Donohoe bought 1,612 Merck shares in Q1 2020, an estimated $127K.
  • Merck made up 0.4% of Osborn Williams & Donohoe's portfolio in Q1 2020, its #72 holding.
  • Osborn Williams & Donohoe first reported a position in Merck in Q2 2013 and has held it in 28 quarters since.
  • Osborn Williams & Donohoe's Merck position peaked at $3.5M in Q4 2019.
  • 2,477 funds tracked by Wall St. Rank held Merck as of Q1 2020.

Based on Osborn Williams & Donohoe's 13F filing for Q1 2020, filed 4 May 2020.